Failure of MIBG scan to detect metastases in SDHB-mutated pediatric metastatic pheochromocytoma. uri icon

Overview

abstract

  • 123 I-meta-iodo benzyl guanidine (MIBG) scans are considered the gold standard imaging in neuroblastoma; however, flouro deoxy glucose positron emission tomography (FDG-PET) scans have increased sensitivity in adults with pheochromocytoma/paraganglioma. We describe a pediatric patient initially considered to have localized neuroblastoma based on anatomical imaging and 123 I-MIBG scan, but subsequent investigations revealed germline succinate dehydrogenase complex iron sulfur subunit B (SDHB) mutation-associated pheochromocytoma with multiple FDG-avid skeletal metastases. We then compared 123 I-MIBG and FDG-PET scans in children with metastatic pheochromocytoma/paraganglioma. FDG-PET was superior to 123 I-MIBG scan for the detection of skeletal metastases (median number of skeletal lesions detected 10 [range 1-30] vs. 2 [range 1-26], respectively; P = 0.005 by t-test). FDG-PET should be considered the functional scan of choice in children with pheochromocytoma/paraganglioma.

publication date

  • April 14, 2017

Research

keywords

  • 3-Iodobenzylguanidine
  • Adrenal Gland Neoplasms
  • Mutation
  • Paraganglioma
  • Pheochromocytoma
  • Succinate Dehydrogenase

Identity

Scopus Document Identifier

  • 85017515699

Digital Object Identifier (DOI)

  • 10.1002/pbc.26549

PubMed ID

  • 28409892

Additional Document Info

volume

  • 64

issue

  • 11